SECURITIES AND EXCHANGE COMMISSION
                       WASHINGTON, D.C. 20549

                             FORM 10-QSB

[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
     SECURITIES EXCHANGE ACT OF 1934

          For the quarterly period ended: November 30, 2003

                                 OR

[   ]    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
     SECURITIES EXCHANGE ACT OF 1934

                    Commission File No.: 0-16035

                        SONO-TEK CORPORATION
  (Exact name of small business issuer as specified in its charter)

    New York                                               14-1568099

(State or other jurisdiction of                           (IRS Employer
incorporation or organization)                          Identification No.)

                    2012 Rt. 9W, Milton, NY 12547
         (Address of Principal Executive Offices) (Zip Code)

     Issuer's telephone no., including area code: (845) 795-2020

Indicate by check mark whether the small business issuer (1) has
filed all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the small business issuer was required
to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.

                           YES X NO _____

                APPLICABLE ONLY TO CORPORATE ISSUERS:

Indicate the number of shares outstanding of each of the issuer's
classes of common stock, as of the latest practicable date:

                                                     Outstanding as of
         Class                                       December 29, 2003

Common Stock, par value $.01 per share                   9,200,161


                        SONO-TEK CORPORATION


                                INDEX




Part I - Financial Information
Page


Item 1 - Consolidated Financial Statements:
1 - 3


Consolidated Balance Sheets - November 30, 2003 (Unaudited) and
     February 28, 2003                                                  1


Consolidated Statements of Operations - Nine Months and Three Months
    Ended November 30, 2003 and 2002 (Unaudited)                        2


Consolidated Statements of Cash Flows - Nine Months and Three Months
    Ended November 30, 2003 and 2002 (Unaudited)                        3


Notes to Consolidated Financial Statements                              4 - 9


Item 2 - Management's Discussion and Analysis of Financial Condition
       and Results of Operations                                       10 - 13

Item 3 - Controls and Procedures                                       14

Part II - Other Information                                            14

Signatures and Certifications                                          15 -18





                        SONO-TEK CORPORATION
                     CONSOLIDATED BALANCE SHEETS

                               ASSETS
                                                November 30,      February 28,
                                                    2003              2003
                                                 Unaudited          Audited
Current Assets
Cash and cash equivalents                         $ 245,527          $ 265,658
Accounts receivable (less allowance of
   $12,046 and $13,675 at November 30 and
   February 28, respectively)                      624,023             375,040
Inventories                                        868,998             794,666
Prepaid expenses and other current assets           84,308              56,023
                                                 ---------           ---------
   Total current assets                          1,822,856           1,491,387
                                                ---------           ---------
Equipment, furnishings and leasehold
   improvements (less accumulated depreciation
   of $665,925 and $638,341 at November 30 and
   February 28, respectively)                       63,552              84,878
Intangible assets, net:
Patents and patents pending                         26,972              29,520
Deferred financing fees                              5,923              11,251
                                                  --------              ------
Total intangible assets                             32,895              40,771
Other assets                                         6,541               6,541
                                                  --------              ------
TOTAL ASSETS                                    $1,925,844          $1,623,577

              LIABILITIES AND STOCKHOLDERS' DEFICIENCY

Current Liabilities:
Accounts payable                                  $203,975            $149,920
Accrued expenses                                   432,656             244,286
Line of Credit                                     312,000             312,000
Current maturities of long term loans
     -related parties                               64,876              63,924
Current maturities of long term debt                 9,072               9,072
Current maturities of subordinated
     mezzanine debt                                212,508             141,672
Current maturities of subordinated loans            18,000              43,428
                                                ----------          ----------
   Total current liabilities                     1,253,087             964,302
Subordinated mezzanine debt                        637,492             690,722
Long term debt, less current maturities            220,904             250,033
Subordinated loans                                 109,674             100,674
Other long-term liabilities                         69,076              69,076
                                                 ---------           ---------
   Total liabilities                             2,290,233           2,074,807
Commitments and Contingencies                          -                   -
Put Warrants                                       188,223             188,223

Stockholders' Equity
Common stock, $.01 par value; 25,000,000
   shares authorized, 9,200,161 shares issued
   and outstanding at November 30 and February 28,
   respectively                                     92,002              92,002
Additional paid-in capital                       6,038,869           6,037,305
Accumulated deficit                             (6,683,483)         (6,768,760)
                                                 ---------           ---------
   Total stockholders' deficiency                 (552,612)           (639,453)
                                                ----------          ----------
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY  $1,925,844          $1,623,577

           See notes to consolidated financial statements.



                        SONO-TEK CORPORATION

                CONSOLIDATED STATEMENTS OF OPERATIONS


                                      Nine Months Ended     Three Months Ended
                                         November 30,           November 30,
                                           Unaudited             Unaudited
                                          2003       2002      2003     2002

Net Sales                             $2,395,002  $2,234,027 $945,745 $748,036
Cost of Goods Sold                     1,018,895     987,895  417,821  301,136
                                       ---------   ---------  -------  -------
  Gross Profit                         1,376,107   1,246,132  527,924  446,900

Operating Expenses
Research and product development costs   269,812     262,800   86,983   99,628
Marketing and selling expenses           477,647     433,318  189,677  150,277
General and administrative costs         420,157     411,863  145,028  123,745
                                       ---------   --------- --------  --------
   Total Operating Expenses            1,167,616   1,107,981  421,688  373,650
                                       ---------   --------- --------  --------
Operating Income                         208,491     138,151  106,236   73,250

Interest Expense                        (130,209)   (168,432) (38,004) (53,104)
Interest and Other Income                  8,105      90,300      250    2,407
                                        --------    --------  -------   ------
Income from Operations
      Before Income Taxes                 86,387      60,019   68,482   22,553
Income Tax Expense                         1,110       3,085        0    2,020
                                        --------    --------  -------   -------
Net Income                              $ 85,277    $ 56,934 $ 68,482   $20,533


Basic Earnings Per Share                   $0.01       $0.01    $0.01     $0.00

Diluted Earnings Per Share                 $0.01       $0.01    $0.01     $0.00

Weighted Average Shares - Basic      9,200,161   9,105,422  9,200,161 9,200,161

Weighted Average Shares - Diluted   10,582,278  10,300,229 10,943,467 9,779,139

           See notes to consolidated financial statements.




                        SONO-TEK CORPORATION
                CONSOLIDATED STATEMENTS OF CASH FLOWS

                                                          Nine Months Ended
                                                            November 30,
                                                              Unaudited
                                                            2003      2002

CASH FLOWS FROM OPERATING ACTIVITIES:
  Net Income                                             $85,277 $ 56,934

  Adjustments to reconcile net income to net
    cash provided by (used in) operating activities:
      Depreciation and amortization                      36,595    57,384
      Imputed interest expense                           17,608    54,815
      Provision for doubtful accounts                    (1,629)  (12,106)
      (Decrease) Increase in:
       Accounts receivable                             (247,354) (100,430)
       Inventories                                      (74,332)   (1,096)
       Prepaid expenses and other current assets        (28,285)   18,647
          Increase (Decrease) in:
       Accounts payable and accrued expenses            242,424   (96,202)
                                                        -------   -------
    Net Cash Provided By (Used In) Continuing Operations 30,304   (22,054)
    Net Cash (Used In) Discontinued Operations                0  (167,403)
                                                        -------   -------
    Net Cash Provided By (Used In) Operating Activities  30,304  (189,457)
                                                        -------   -------

CASH FLOW FROM INVESTING ACTIVITIES:
  Patent Application Costs                               (1,137)  (10,795)
  Purchase of equipment and furnishings                  (6,257)   (8,159)
  Deposits                                                 0         (375)
                                                         ------   -------
    Net Cash Used In Investing Activities                (7,394)  (19,329)
                                                         ------   -------
CASH FLOW FROM FINANCING ACTIVITIES:
  Proceeds from issuance of stock                             0    18,000
  Proceeds from the issuance of  options                  1,564         0
    Repayments of loans - related parties               (21,373)  (44,385)
  Repayments of note payable and equipment loans         (6,804)  (49,375)
  Repayments of subordinated loans                      (16,428)   (3,695)
                                                        -------    ------
      Net Cash Used In Financing Activities             (43,041)  (79,455)
                                                        -------    ------

NET DECREASE IN CASH AND CASH EQUIVALENTS               (20,131) (288,241)

CASH AND CASH EQUIVALENTS
  Beginning of period                                   265,658   453,215
                                                       --------  --------
  End of period                                        $245,527  $164,974

SUPPLEMENTAL DISCLOSURE:
  Interest paid                                        $103,964  $135,676

           See notes to consolidated financial statements.




                        SONO-TEK CORPORATION
             Notes to Consolidated Financial Statements
            Nine Months Ended November 30, 2003 and 2002


NOTE 1:  SIGNIFICANT ACCOUNTING POLICIES

Consolidation - The accompanying consolidated financial statements
of Sono-Tek Corporation, a New York Corporation (the "Company"),
include the accounts of the Company and its wholly owned
subsidiary, Sono-Tek Cleaning Systems, Inc., a New Jersey
Corporation ("SCS"), that the Company acquired on August 3, 1999.
SCS is a non-operating entity.  All significant intercompany
accounts and transactions are eliminated in consolidation.

Interim Reporting - The attached summary consolidated financial
information does not include all disclosures required to be included
in a complete set of financial statements prepared in conformity
with accounting principles generally accepted in the United States
of America.  Such disclosures were included with the financial
statements of the Company at February 28, 2003, and included in its
report on Form 10-KSB.  Such statements should be read in
conjunction with the data herein.

The financial information reflects all adjustments, which, in the
opinion of management, are necessary for a fair presentation of the
results for the interim periods presented.  The results for such
interim periods are not necessarily indicative of the results to be
expected for the year.

Stock-Based Employee Compensation - The Company accounts for
stock-based compensation plans utilizing the provisions of
Accounting Principles Board Opinion No. 25 (APB 25), "Accounting
for Stock Issued to Employees" and the Financial Accounting
Statement of Financial Accounting Standards No. 123 and No. 148
(SFAS 123 and SFAS 148), "Accounting for Stock-Based
Compensation".  Under SFAS 123, the Company will continue to apply
the provisions of APB 25 to its stock-based employee compensation
arrangements, and is only required to supplement its financial
statements with additional pro-forma disclosures.  The Company has
elected to provide the related pro-forma disclosures utilizing an
intrinsic value method of accounting for such stock based
compensation.

The estimated fair value of options granted during Fiscal Year 2003
was $.22 per share and the estimated fair value of options granted
during the nine months ended November 30, 2003 was $.20 per share.
The Company applies Accounting Principles Board Opinion No. 25 and
related interpretations in accounting for the 1993 Plan.  Had
compensation cost for the Company's stock option plan been
determined based on the intrinsic value at the option grant dates
for awards in accordance with the accounting provisions of SFAS
123, the Company's net income and basic and diluted earnings per
share for the nine and three month periods ended November 30, 2003
and 2002 would have been changed to the pro forma amounts indicated
below:


                                 Nine Months Ended      Three Months Ended
                                    November 30,             November 30,
                                 2003          2002         2003      2002
Net income (loss):
     As reported               $85,277       $56,934      $68,482   $20,533
Deduct: Total stock based
 employee compensation
 under intrinsic value
 based method for all
 awards, net of taxes            6,363       89,483         2,326    66,567
Pro forma net income (loss)    $78,914     $(32,549)      $66,156  $(46,034)
Basic and diluted earnings per share:
     As reported                 $0.01        $0.01         $0.01     $0.01
     Pro forma                   $0.01        $0.00         $0.01     $0.00

At the August 21, 2003 Annual Meeting of Shareholders, the Company
adopted a new Stock Incentive Plan (the "2003 Plan").  Under this
plan, up to 1,500,000 stock options can be granted until 2013.  To
date, no options have been granted under this plan.

Patent and Patent Pending Costs - Cost of patent applications are
deferred and charged to operations over seventeen years for
domestic patents and twelve years for foreign patents. However, if
it appears that such costs are related to products that are not
expected to be developed for commercial application within the
reasonably foreseeable future, or are applicable to geographic
areas where the Company no longer requires patent protection, they
are written off to operations.  The accumulated amortization is
$69,455 and $65,770 at November 30, 2003 and February 28, 2003,
respectively.

Accounting for Financial Instruments - In May 2003, the FASB issued
Statements of Financial Accounting Standards No. 150 ("SFAS No.
150") "Accounting for Certain Financial Instruments with
Characteristics of Both Liabilities and Equity".  SFAS No. 150
established standards for how an issuer classifies and measures in
its statement of financial position certain financial instruments
with characteristics of both liabilities and equity. It requires
that an issuer classify a financial instrument that is within its
scope as a liability (or an asset in some circumstances) because
that financial instrument embodies an obligation of the issuer.
This SFAS is effective for financial instruments entered into or
modified after May 31, 2003 and otherwise is effective at the
beginning of the first interim period beginning after June 15,
2003. It is to be implemented by reporting the cumulative effect of
a change in accounting principle for financial instruments created
before the issuance date of SFAS No. 150 and still existing at the
beginning of the interim period of adoption. Restatement is not
permitted.  The adoption of SFAS No. 150 has required the Company
to have additional disclosures regarding the Put Warrants and did
not have a material effect on the financial statements.  The
Company adopted SFAS No. 150 in the three months ended May 31, 2003.


NOTE 2:  INVENTORIES

Inventories at November 30, 2003 are comprised of:

         Finished goods                         $424,924
         Work in process                         326,177
         Consignment                               3,342
         Raw materials and subassemblies         312,587
                                               ---------
                  Total                        1,067,030
         Less: Allowance                        (198,032
                                               ---------
         Net inventories                       $868,998

NOTE 3:  RELATED PARTY TRANSACTIONS

Short-term loans - related parties - At Fiscal Year End 2002, loans
from directors and former officers in the amount of $286,084 plus
accrued interest of $62,728 were formalized into four-year notes
bearing interest at 5% on the unpaid balance.  Repayments of these
notes commenced on March 31, 2002.  Payments of $95,086 of
principal and interest due in the period from August 31, 2002 to
November 30, 2003 have been deferred in order to maintain the
Company's liquidity.

Certain of the Company's directors, an officer and an affiliate are
participants with Norwood Venture Corporation ("Norwood") in its
subordinated mezzanine financing.

NOTE 4:  SUBORDINATED MEZZANINE DEBT

On September 30, 1999, the Company entered into a 12%, $450,000
Note and Warrant Purchase Agreement (the "Agreement") with
Norwood.  On December 22, 2000, Norwood amended the Agreement to
increase the note to $550,000.  On April 30, 2001, Norwood amended
the Agreement to increase the note by $300,000 to $850,000 and the
warrant shares to 2,077,777.  The Norwood Note (the "Note"), as
amended, requires interest payments through September 2002,
followed by monthly principal payments of $23,612 and interest
through September 2005.  Certain assets of the Company
collateralize the Note.  The Note, among other things, restricts
the payment of dividends.  The monthly principal payments to
commence in October 2001 were $23,612 per month and have been
deferred until March 2004.

In addition, the original Note was issued with a detachable stock
purchase warrant (the "Put Warrants") to purchase 1,100,000 shares
of the Company's common stock at an exercise price of $.30 per
share, the fair market value of the Company's common stock on
September 30, 1999.  The fair market value, as determined by an
independent appraisal, of the Put Warrants was determined to be
$0.07 per share, and is accounted for as a discount to the Norwood
Noteand will be amortized over the life of the principal repayment
term of the Agreement.  In connection with the amendments, dated
December 22, 2000 and April 30, 2001,an additional 244,444 and
733,333 warrant shares were granted at an exercise price of $0.30
and $.10 per share, respectively.  In connection with an amendment
to the Agreement in October 2001, the exercise price of certain of
the warrants was reduced from $.30 to $.15 per share.  This
resulted in an increase in the value of the warrants of $13,445,
which is accounted as a discount to the loan and is being imputed
as additional interest over the term of the loan.  The aggregate
exercise price of the Put Warrants is $275,000 for the purchase of
2,077,777 shares of common stock

The Put Warrant holders may, commencing after the delivery of the
February 28, 2006 audited financial statements and terminating one
year thereafter, require the Company to purchase such warrants at a
price equal to the result calculated by subtracting the aggregate
exercise of the warrants to the extent remaining from the product of
the greatest of:

a)   the fair market value of the Company as determined by an
     independent appraiser as at the end of the Company's fiscal
     year end February 28, 2006 (the "Company's 2006 Fiscal Year"),

b)   five times EBITDA for the Company's 2006 Fiscal Year or, if
     higher, average EBITDA for such year and the fiscal year of the
     Company immediately prior to such year, or

c)   the book value of the Company as at the end of the Company's
     2006 Fiscal Year,

multiplied by the fraction of (the "Put Fraction") the numerator of
which is the total number of shares of common stock the Put Warrant
holders would own upon such exercise of the warrants and the
denominator would be the total number of common shares outstanding
upon the exercise of all equity rights to acquire common stock.  The
Norwood Agreement provides for pre-emptive rights to purchase equity
from the Company at the most favorable terms offered to others.

If the Company, based upon its fair value computed using its Fiscal
Year 2006 results, is required to pay the Put under the warrants,
warrant holders will have to pay up to $275,000 for the warrants.
Upon measurement and exercise, one third of such put payment by the
Company would be due immediately, with the balance payable over 36
months with interest at 12%.



NOTE 5: DEFERRAL OF PAYMENTS

The Company, in order to conserve its cash assets, has agreements to
defer payment of certain of its obligations at November 30, 2003.
Such deferrals were:

Current maturities of subordinated mezzanine debt                $330,568
Current maturities of long-term loans - related parties            81,518
Current maturities of subordinated loans                           50,421
Incentive compensation                                             18,067
Interest                                                           13,567
                                                                  -------
                  Total                                          $494,141

NOTE 6: STOCK OPTIONS AND WARRANTS

Stock Options - Under the 1993 Stock Incentive Plan, as amended
("1993 Plan"), options can be granted to officers, directors,
consultants and employees of the Company and its subsidiaries to
purchase up to 1,500,000 of the Company's common shares.  Options
granted under the 1993 Plan expire on various dates through 2013.
As of November 30, 2003, there were 1,057,562 options outstanding
under the 1993 Plan and no further grants are allowable.

The Company's shareholders approved the 2003 Stock Incentive Plan
("2003 Plan") at the August 21, 2003 meeting of shareholders.  Under
the 2003 Plan, options can be granted to officers, directors,
consultants and employees of the Company and its subsidiaries to
purchase up to 1,500,000 of the Company's common shares.  To date,
there have been no options granted under this plan.

Under both the 1993 and 2003 Stock Incentive Plans, option prices
must be at least 100% of the fair market value of the common stock
at time of grant.  For qualified employees, except under certain
circumstances specified in the plans or unless otherwise specified
at the discretion of the Board of Directors, no option may be
exercised prior to one year after date of grant, with the balance
becoming exercisable in cumulative installments over a three year
period during the term of the option, and terminate at a stipulated
period of time after an employee's termination of employment.

Under the 1993 Plan, during Fiscal Year 2003, the Company granted
options for 405,000 shares exercisable at between $0.15 per share
and $0.30 per share to qualified employees and 40,000 shares
exercisable at $0.37 to directors of the Company.  The Company
granted options for 20,000 shares exercisable at $0.25 to a
director of the Company and options for 10,000 shares exercisable
at $0.19 to a consultant in the nine months ended November 30,
2003.

Warrants - There were no warrants issued during Fiscal 2004 and
2003.  370,175 warrants issued in 1999 in conjunction with the
retirement of subordinated debt expired in Fiscal 2003.


NOTE 7:  EARNINGS PER SHARE

The denominator for the calculation of diluted earnings per share at
November 30, 2003 and 2002 are calculated as follows:
                              Nine Months         Three Months
                                Ended               Ended
                              November 30,        November 30,
                              2003     2002      2003      2002

Denominator for
  basic earnings per share 9,200,161 9,105,422 9,200,161  9,200,161

Dilutive effect of
  warrants                 1,161,111 1,129,501 1,423,015    550,000
Dilutive effect of
  stock options              221,007    65,305   320,290     28,978

Denominator for dilutive
 earnings per share       10,582,278 10,300,229 10,943,467 9,779,139



                        SONO-TEK CORPORATION

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
                      AND RESULTS OF OPERATIONS

Forward-Looking Statements

Certain statements made in this report may constitute
"forward-looking statements" within the meaning of the Federal
Securities Laws.  Such forward-looking statements include
statements regarding the intent, belief or current expectations of
the Company and its management and involve known and unknown
risks, uncertainties and other factors which may cause the actual
results, performance or achievements of the Company to be
materially different from any future results, performance or
achievements expressed or implied by such forward-looking
statements.  Such factors include, among other things, the
following:

-     The Company's ability to respond to competition in its
      markets;

-     General economic conditions in the Company's markets; and

-     Ability to continue to obtain deferral of principal payments
      from its note holders.

The Company undertakes no obligation to update publicly any
forward-looking statement.

Liquidity and Capital Resources

The Company's working capital increased $42,684 from $527,085 at
February 28, 2003 to $569,769 at November 30, 2003.  The increase in
working capital was a result of an increase in accounts receivable
of $249,000, an increase in inventory of $74,000 an increase in
prepaid expenses of $28,000, that was offset by an increase in
accounts payable of $54,000, an increase in accrued expenses of
$188,000, an increase in the current maturities of debt of $46,000
and a decrease in cash of $20,000.  The stockholders' deficiency
decreased $86,841 from $639,453 at February 28, 2003 to $552,612 at
November 30, 2003.  The decrease in stockholders' deficiency was
principally the result of the net profit of $85,277 for the nine
months ended November 30, 2003.

Accounts receivable at November 30, 2003 increased $248,983 or 66%
from February 28, 2003 due to higher sales levels in the last
month of this quarter as compared to the last month of the fourth
quarter of the prior fiscal year.

Inventory increased $74,332 or 9% as the result of increased
demand for the Company's products in the current quarter.  The
increase was the result of newly introduced products.

Prepaid expenses increased $28,285 or 50% as the result of a
deposit made for contractual work being performed on equipment to
be delivered next quarter.

Accounts payable and accrued expenses increased $54,055 or 36% as
compared to February 28, 2003 due to purchases made to support
increased shipments.

Accrued expenses increased $188,370 or 7% principally as the
result of increased accrued compensation expense, increased
commissions and increased customer deposits.

The Company currently has a $350,000 line of credit with a bank, in
the form of a demand note.  The loan is collateralized by accounts
receivable, inventory and all other personal property of the Company
and is guaranteed by the former Chief Executive Officer of the
Company.  As of November 30, 2003 and February 28, 2003 the
outstanding balance was $312,000.  New borrowings are presently
precluded under this note.

Results of Operations

For the nine months ended November 30, 2003, the Company's sales
increased $160,975, or 7.2%, to $2,395,002 as compared to $2,234,027
for the nine months ended November 30, 2002.  The increase was a
result of an increase in fluxer sales of $341,000, an increase in
nozzle sales of $15,000, partially offset by a decrease in sales of
specialty spraying systems of $190,000 and cleaning system spare
part sales of $6,000.

For the three months ended November 30, 2003, the Company's sales
increased $197,709, or 26.4%, to $945,745 as compared to $748,036
for the three months ended November 30, 2002.  The increase was a
result of an increase in fluxer sales of $300,000, nozzle sales of
$2,000, and cleaning system spare part sales of $15,000, partially
offset by a decrease in sales of specialty spraying systems of
$120,000.

The Company's gross profit increased $129,974 to $1,376,107 for the
nine months ended November 30, 2003 from $1,246,133 for the nine
months ended November 30, 2002.  The gross profit margin was 57.5%
of sales for the nine months ended November 30, 2003 as compared to
55.8% of sales for the nine months ended November 30, 2002.  The
change in margin occurred as the result of the changing mix of
products in each period.

The Company's gross profit increased $15,959 to $409,179 for the
three months ended August 31, 2003 from $393,220 for the three
months ended August 31, 2002.  The gross profit margin was 59.2% of
sales for the three months ended August 31, 2003 as compared to
55.8% of sales for the three months ended August 31, 2002.  The
change in margin occurred as the result of the changing mix of
products in each period.

Research and product development costs increased $7,012 to $269,812
for the nine months ended November 30, 2003 from $262,800 for the
nine months ended November 30, 2002.  The increase was due to
increased labor and fringes of $13,000, partially offset by reduced
travel of $3,000 and reduced costs for facility, utilities and
supplies.  Research and product development costs of $50,000
incurred in the nine months ended November 30, 2002 were used to
manufacture saleable inventory items, and accordingly, were recorded
in inventory.  During the nine months ended November 30, 2003
research and development personnel were not utilized for
manufacturing.

Research and product development costs decreased $12,645 to $86,983
for the three months ended November 30, 2003 from $99,628 for the
three months ended November 30, 2002.  The decrease was due to less
engineering materials purchased this year.

Marketing and selling costs increased $44,329 and $39,400 for the
respective nine and three month periods ended November 30, 2003 as
compared to the same periods ended November 30, 2002.  The increases
were due principally to increased commissions partially offset by
reduced labor and fringe benefits, facility, utility and trade show
costs.

General and administrative costs increased $21,283 and $8,294 for
the respective six and three month periods ended November 30, 2003
as compared to the same periods ended November 30, 2002.  The
increase was due principally to increased payroll, legal, travel and
relocation costs partially offset by reduced bank fees and
consulting expenses.

Interest expense decreased $38,223 to $130,209 for the nine months
ended November 30, 2003 from $168,432 for the nine months ended
November 30, 2002.  Interest expense decreased $15,100 to $38,004
for the three months ended November 30, 2003 from $53,104 for the
three months ended November 30, 2002.  The decrease is primarily due
to reduced interest and amortization on the Norwood loans and
reduced interest on related party and bank loans.

Interest and other income decreased $82,195 for the nine months
ended November 30, 2003 as compared to the nine months ended
November 30, 2002 and $2,157 for the three months period ended
November 30, 2003 as compared to the three month period ended
November 30, 2002.  The decreases are primarily due to settlements
with former vendors and sales representatives, and a reduction of
the accrual for future rent expense recorded in the prior year's
periods.

The Company's net income was $85,277 and $68,482 for the six and
three month periods ended November 30, 2003 as compared to $56,934
and $20,533 for the nine and three month periods ended November 30,
2002.

Critical Accounting Policies

The discussion and analysis of the Company's financial condition and
results of operations are based upon the consolidated financial
statements, which have been prepared in accordance with accounting
principles generally accepted in the United States of America.  The
preparation of these financial statements requires the Company to
make estimates and judgments that affect the reported amount of
assets and liabilities, revenues and expenses, and related
disclosure on contingent assets and liabilities at the date of the
financial statements.  Actual results may differ from these
estimates under different assumptions and conditions.

Critical accounting policies are defined as those that are
reflective of significant judgments and uncertainties, and may
potentially result in materially different results under different
assumptions and conditions.  The Company believes that critical
accounting policies are limited to the one described below.  For a
detailed discussion on the application of this and other accounting
policies see note 3 to the Company's consolidated financial
statements included in Form 10-KSB for the year ended February 28,
2003.

Accounting for Income Taxes

As part of the process of preparing the Company's consolidated
financial statements, the Company is required to estimate its income
taxes.  Management judgment is required in determining the provision
on its deferred tax asset.  The Company recorded a valuation reserve
for the full deferred tax asset from the net operating losses
carried forward due to the Company not demonstrating consistent
profitable operations.  In the event that actual results differ from
these estimates or the Company adjusts these estimates in future
periods, the Company may need to adjust such valuation reserve
recorded.

Impact of New Accounting Pronouncements

In May 2003, the FASB issued Statements of Financial Accounting
Standards No. 150 ("SFAS No. 150"), "Accounting for Certain
Financial Instruments with Characteristics of Both Liabilities and
Equity".  SFAS No. 150 established standards for how an issuer
classifies and measures in its statement of financial position
certain financial instruments with characteristics of both
liabilities and equity.  It requires that an issuer classify a
financial instrument that is within its scope as a liability (or an
asset in some circumstances) because that financial instrument
embodies an obligation of the issuer.  This SFAS is effective for
financial instruments entered into or modified after May 31, 2003
and otherwise is effective at the beginning of the first interim
period beginning after June 15, 2003.  It is to be implemented by
reporting the cumulative effect of a change in accounting principle
for financial instruments created before the issuance date of SFAS
No. 150 and still existing at the beginning of the interim period
of adoption. Restatement is not permitted.  The adoption of SFAS
No. 150 has required the Company to have additional disclosures
regarding the Put Warrants and did not have a material effect on
the financial statements. The Company adopted SFAS No. 150 in the
three months ended May 31, 2003.










                         SONO-TEK CORPORATION
                        CONTROLS AND PROCEDURES

The Company has established and maintains "disclosure controls and
procedures" (as those terms are defined in Rules 13a - 14(c) and
15d-14(c) under the Securities and Exchange Act of 1934 (the
"Exchange Act").  Christopher L. Coccio, Chief Executive Officer and
President (principal executive and accounting officer) of the
Company, has evaluated the Company's disclosure controls and
procedures as of November 30, 2003.  Based on his evaluation, Dr.
Coccio has concluded that the Company's disclosure controls and
procedures are effective to ensure that the information required to
be disclosed by the Company in reports that it files or submits
under the Exchange Act is recorded, processed, summarized and
reported within the time periods specified by SEC rules and forms.

There were no significant changes in the Company's internal
controls or in other factors that could significantly affect these
controls after November 30, 2003.  There were no significant
deficiencies or material weaknesses, and therefore there were no
corrective actions taken.

                     PART II - OTHER INFORMATION

     Item 1.  Legal Proceedings
           None

     Item 2.  Changes in Securities and Use of Proceeds.
           None

     Item 3.  Defaults Upon Senior Securities
           None

     Item 4.  Submission of Matters to a Vote of Security Holders
           None

     Item 5.  Other Information
           None

     Item 6.  Exhibits and Reports on Form 8-K
(a)      Exhibits
            31 - Rule 13a - 14(a)/15d - 14(a) Certification
            32 - Certification Pursuant to 18 U.S.C. Section 1350

           (b)Reports on Form 8-K
              The Company filed a report on Form 8-K on October 15,
         2003 relating to a press release on the results of
         operations for the quarter ended August 31, 2003.



                             SIGNATURES


In accordance with the requirements of the Exchange Act, the
registrant has caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.

Dated: December 29, 2003


                                SONO-TEK CORPORATION
                                    (Registrant)


                                /s/ Christopher L. Coccio
                           By: ____________________________________
                                Christopher L. Coccio
                           Chief Executive Officer and President
                     (principal executive and accounting officer)



                                                           Exhibit 31

                RULE 13a-14/15d - 14(a) CERTIFICATION

I, Christopher L. Coccio, Chief Executive Officer and President
(principal executive and accounting officer), certify that:

1.   I have reviewed this quarterly report on Form 10-QSB of
     Sono-Tek Corporation;

2.   Based on my knowledge, this quarterly report does not contain
     any untrue statement of a material fact or omit to state a
     material fact necessary to make the statements made, in light
     of the circumstance under which such statements were made, not
     misleading with respect to the period covered by this quarterly
     report;

3.   Based on my knowledge, the financial statements, and other
     financial information included in this quarterly report, fairly
     present in all material respects the financial condition,
     results of operations and cash flows of the small business
     issuer as of, and for the periods presented in this quarterly
     report;

4.   I am responsible for establishing and maintaining disclosure
     controls and procedures (as defined in Exchange Act Rules
     13a-15(e) and 15d - 15(e) and internal control over financial
     reporting (as defined in Exchange Act Rules 13a-15(f) and
     15d-15(f) for the small business issuer and I have:

         a) Designed such disclosure controls and procedures, or
         caused such disclosure controls and procedures to be
         designed under my supervision, to ensure that material
         information relating to the small business issuer,
         including its consolidated subsidiaries, is made known to
         me by others within those entities, particularly during the
         period in which this report is being prepared;

         b) Designed such internal control over financial reporting,
         or caused such internal control over financial reporting to
         be designed under my supervision, to provide reasonable
         assurance regarding the reliability of financial reporting
         and the preparation of financial statements for external
         purposes in accordance with generally accepted accounting
         principles;

         c) Evaluated the effectiveness of the small business
         issuer's disclosure controls and procedures and presented
         in this report my conclusions about the effectiveness of
         disclosure controls and procedures, as of the end of the
         period covered by this report based on such evaluation; and

         d) Disclosed in this report any change in the small
         business issuer's internal control over financial reporting
         that occurred during the small business issuer's most
         recent fiscal quarter that has materially affected, or is
         reasonably likely to materially affect, the small business
         issuer's internal control over financial reporting; and

5.   I have disclosed, based on my most recent evaluation of
     internal control over financial reporting, to the small
     business issuer's auditors and the audit committee of the small
     business issuer's board of directors:

a)   All significant deficiencies and material weaknesses in the
            design or operation of internal control over financial
            reporting which are reasonably likely to adversely
            affect the small business issuer's ability to record,
            process, summarize and report financial information; and

b)   Any fraud, whether or not material, that involves management or
            other employees who have a significant role in the small
            business issuer's internal controls over financial
            reporting.

   Date:  December 29, 2003

   /s/ Christopher L. Coccio
   Christopher L. Coccio
   Chief Executive Officer and President
   (principal executive and accounting officer)


                                                           Exhibit 32

                      CERTIFICATION PURSUANT TO
                       18 U.S.C. SECTION 1350,
                       AS ADOPTED PURSUANT TO
            SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Sono-Tek Corporation on
Form 10QSB for the period ended November 30, 2003 as filed with the
Securities and Exchange Commission on the date hereof (the
"Report").  I, Christopher L. Coccio, Chief Executive Officer and
President (principal executive and accounting officer) of the
Company, certify, pursuant to 18 U.S.C. section 1350, as adopted
pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)  The Report fully complies with the requirements of section
           13(a) and 15(d) of the Securities Exchange Act of 1934;
           and

(2)  The information contained in the Report fairly presents, in all
           material respects, the financial condition and result of
           operations of the Company.

Date: December 29, 2003

/s/ Christopher L. Coccio
Christopher L. Coccio
Chief Executive Officer and President
(principal executive and accounting officer)